# Precigen, Inc.: Form 8-K, filed Dec 30, 2024

- Company: [Precigen, Inc.](/companies/pgen.md) (CIK 1356090)
- Form: 8-K
- Filed: 2024-12-30
- Accepted by EDGAR: Dec 30, 2024, 16:18 ET
- Period: 2024-12-27
- Accession: 0000950103-24-018479
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1356090/000095010324018479/dp222802_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1356090/000095010324018479/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1356090/000095010324018479/dp222802_8k.htm

Filed Dec 30, 2024.
Source: SEC EDGAR, the filing index for accession 0000950103-24-018479. Last ingested by Listed: Nov 4, 2026, 17:17 ET. No prices; not investment advice.